GILD vs SUN · P/E 18, rev $29.44B vs P/E 16, rev $22.69B
Gilead Sciences Inc (GILD) versus Sunoco LP (SUN) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Sunoco LP (SUN) is a oil & gas refining & marketing company listed on NYSE.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported SUN revenue for 2024-12-31 was $22.69B. Net income was $874.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
Not investment advice. Open the GILD and SUN stock pages for the full models.
Not investment advice.